Optimising symptom management in children with cancer using a novel mobile phone application: protocol for a controlled hybrid effectiveness implementation trial (RESPONSE)
Open Access
- 9 September 2021
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 21 (1) , 1-10
Abstract
Background: Intense and aggressive treatment regimens for most children’s cancer have achieved vast improvements in survival but are also responsible for both a high number and burden of symptoms. The use of Patient Reported Outcome Measures (PROMs) demonstrates a range of benefits for improved symptom management in adults with cancer. There are, however, multiple barriers to integrating PROMs into routine care in children and adolescents with cancer. This study aims to evaluate: (1) the effectiveness of electronic PROMs to generate stratified alerts, symptom management recommendations and graphical summaries (the RESPONSE system) to improve health outcomes and (2) the implementation of the RESPONSE system by assessing feasibility, acceptability, satisfaction, and sustainability. Methods: A pragmatic hybrid II effectiveness-implementation controlled trial, using mixed methods, will be undertaken, advancing both knowledge of the effectiveness of the intervention and implementation factors. One-hundred and sixty children with cancer receiving active treatment will be recruited 1:1 to a non-randomised study involving two groups with an equal number of participants in each group. The intervention group (n = 80) will be prospectively recruited to receive the RESPONSE system intervention over eight weeks, versus the historical matched control group (n = 80) who will complete the ePROMs without access to the RESPONSE system. The primary outcome of the effectiveness trial is change between groups in total symptom burden. Secondary outcomes include child health-related quality-of-life and implementation outcomes. Trial data will be analysed using linear mixed-effects models. Formative implementation evaluation is informed by CFIR and ERIC frameworks and implementation outcomes will be mapped to the RE-AIM framework and include interviews, field notes, as well as administrative data to evaluate feasibility, acceptability, satisfaction and sustainability. Trial registration number: ACTRN12621001084875. Retrospectively Registered 16 August 2021.Keywords
Funding Information
- National Health and Medical Research Council (APP174733)
- Children's Hospital Foundation Queensland (Health Services Pre-Clinical Round)
This publication has 46 references indexed in Scilit:
- Using the framework method for the analysis of qualitative data in multi-disciplinary health researchBMC Medical Research Methodology, 2013
- A systematic review of symptom assessment scales in children with cancerBMC Cancer, 2012
- Effectiveness-implementation Hybrid DesignsMedical Care, 2012
- Feasibility of using a handheld electronic device for the collection of patient reported outcomes data from childrenJournal of Communication Disorders, 2012
- Management of Pediatric Oncology Pain in the Home SettingJournal of Pediatric Hematology/Oncology, 2011
- Distress screening, rater agreement, and services in pediatric oncologyPsycho-Oncology, 2010
- Changes in Children’s Reports of Symptom Occurrence and Severity During a Course of Myelosuppressive ChemotherapyJournal of Pediatric Oncology Nursing, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- The PedsQL™ brain tumor module: Initial reliability and validityPediatric Blood & Cancer, 2006
- Evaluating the public health impact of health promotion interventions: the RE-AIM framework.American Journal of Public Health, 1999